Historical record - last NADAC publication: 8/21/2019
Product Information
CARBIDOPA-LEVO 25-250 MG ODT is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.9412 per EA under NDC 47335018888. Its NADAC has been published 52 times since Aug 21, 2019.
Strength
25; 250 mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335018888
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
8/21/2019
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA078690On Market Since
12/15/2014
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVO 25-250 MG ODT has been published 52 times since Aug 21, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9412 per EA |
|---|---|
| All-time high | $0.9412 (Aug 12, 2020) |
| All-time low | $0.9412 (Aug 21, 2019) |
| Median price | $0.9412 |
| Average price | $0.9412 |
| Largest weekly change | 0.0% (Aug 28, 2019) |
| Weeks tracked | 52 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVO 25-250 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO 25-250 MG ODT, manufactured by Sun Pharmaceutical Industries Inc., is $0.9412 per EA (NDC 47335018888), effective Aug 12, 2020.
How has the price of CARBIDOPA-LEVO 25-250 MG ODT changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVO 25-250 MG ODT has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO 25-250 MG ODT?
Since Aug 21, 2019, the NADAC for CARBIDOPA-LEVO 25-250 MG ODT has ranged from a low of $0.9412 (Aug 21, 2019) to a high of $0.9412 (Aug 12, 2020), with a median of $0.9412 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVO 25-250 MG ODT?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CARBIDOPA-LEVODOPA 25-250 TAB, is $0.1149 per EA — about 88% below CARBIDOPA-LEVO 25-250 MG ODT.
Who manufactures CARBIDOPA-LEVO 25-250 MG ODT?
CARBIDOPA-LEVO 25-250 MG ODT (NDC 47335018888) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification